HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

2nd Edition of International Heart Congress

June 20-22,2024 | Hybrid Event

June 20 -22, 2024 | Paris, France

Heart Congress 2024

 Michael E Merhige, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Michael E Merhige, State University of NY at Buffalo, United States

Background: External Counter Pulsation (ECP) is an FDA approved, noninvasive, treatment for patients with refractory angina, who are not candidates for low-risk interventional revascularization, such as those with chronic total coronary occlusion (CTO). ECP uses sequentially [....] » Read More

Yong Xiao Wang, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Yong Xiao Wang, Albany Medical Center, United States

Pulmonary hypertension (PH) is a common and devastating lung disease. The current primary medications for this disease are to use non-specific vasodilators, but patients do not always respond well to non-specific vasodilators. Voltage-dependent potassium channels and store-operat [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Keynote Presentation (In-Person)
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation

A new systems approach to diseased states and wellness result in a new branch in the healthcare ser-vices, namely Personalized and Precision Medicine (PPM). To achieve the implementation of PPM concept, it is necessary to create a fundamentally new strategy based upon the re [....] » Read More

Dipak P Ramji, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Dipak P Ramji, Cardiff University, United Kingdom

Atherosclerosclerotic cardiovascular disease (ACVD) is responsible for a third of all global deaths. Although a reduction in morbidity and mortality from ACVD has been achieved recently by lifestyle changes and pharmaceutical intervention, this is expected to reverse in the futur [....] » Read More

Prabode Weebadde, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Prabode Weebadde, Purdue University, United States

In the U.S., every year, about 800,000 people die due to cardiovascular diseases (CVD) or diseases related to the heart and blood vessels. Of those 800,000, 650,000 deaths were related to the heart, and 150,000 were related to blood vessels. To put it in another perspective, ever [....] » Read More

Blake I Gardner, Speaker at Heart Conferences
Oral Presentation (In-Person)
Blake I Gardner, Intermountain Health, United States

Intermountain Health is a large integrated healthcare institution in the western United States that prioritizes value-based care, even at times when it appears contrary to regional and national payment models. Because of this focus, Intermountain Health has been at the forefront [....] » Read More

Sergey Suchkov, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Sergey Suchkov, The Russian University for Medicine & The Russian Academy of Natural Sciences, Russian Federation

Catalytic Abs (catAbs) are multivalent immunoglobulins (Igs) with a capacity to hydrolyze the antigenic (Ag) substrate. In this sense, proteolytic Abs (Ab-proteases) represent Abs to provide proteolytic effects. Autoimmune myocarditis (AIM) can be defined as the autoimmune i [....] » Read More

Lusine Harutyunyan, Speaker at Cardiology Conferences
Oral Presentation (In-Person)
Lusine Harutyunyan, Adventist Health, United States

Importance on multidisciplinary approach to cardiovascular patients- specifically ASCVD and CHF groups. Financial and socioeconomic burden of cardiovascular disease and ways to improve patient outcomes and patient satisfaction. Will discuss ways to standardize medical care. ACC/A [....] » Read More

Vahid Serpooshan, Speaker at Heart Conferences
Oral Presentation (In-Person)
Vahid Serpooshan, Emory University and Georgia Institute of Technology, United States

Human cardiogenesis is a finely orchestrated process that involves dynamic genetic and morphological changes. However, the cellular and microenvironmental processes underlying the human heart development remain obscure, due to limited access to human heart in utero and the lack o [....] » Read More

Qazi Naeem ur Rehman, Speaker at Heart Conferences
Oral Presentation (In-Person)
Qazi Naeem ur Rehman, Wirral University Teaching Hospital NHS Foundation Trust Wirral, United Kingdom

Introduction: Heart failure affects more than 64 million people worldwide and causes significant morbidity and mortality. The prevalence of iron deficiency (ID) can reach up to 59% in patients with heart failure. ID is an independent predictor of outcomes and major contributor to [....] » Read More

T Rajini Samuel, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
T Rajini Samuel, Shri Sathya Sai Medical College and Research Institute, India

Introduction: Electrocardiogram (ECG) has offered immense clinical value for more than a century yet its interpretation remains an arduous task and ECG phobia  develops in some of the junior doctors and staff nurses often seeking the help of medical experts in that field. Ei [....] » Read More

Vivek Vaibhav, Speaker at Heart Conferences
Oral Presentation (In-Person)
Vivek Vaibhav, Rama Medical College, India

Dilated cardiomyopathy (DCM) is a myocardial disease characterised by ventricular dilatation and global myocardial dysfunction (ejection fraction < 40%). Patients usually present with symptoms of biventricular failure, e.g. fatigue, dyspnoea, orthopnoea, ankle oedema A [....] » Read More

Merab Beraia, Speaker at Heart Conferences
Oral Presentation (In-Person)
Merab Beraia, Tbilisi State University, Georgia

At the beginning of blood flow, red blood cells (RBCs) align in the central plane of the vessels. In capillaries, RBCs change from a biconcave disk to a parachute shape and as blood moves from the arterial to the venous end, hemoglobin in erythrocytes alters magnetic susceptibili [....] » Read More

Cristina Milagre Quadros Borges, Speaker at Heart Conferences
Oral Presentation (In-Person)
Cristina Milagre Quadros Borges, Hcor- Heart Hospital of Sao Paulo, Brazil, Brazil

Smoking is considered a chronic disease, caused by chemical dependence of nicotine. This is highly addicting, it in the brain system, it  infuences our emotions increases the feeling of pleasure/humor and reduces the anxiety. In a planet with about 8 billion people, around 1 [....] » Read More

Samia Barbouch, Speaker at Heart Conferences
Poster Presentation (In-Person)
Samia Barbouch, Charles Nicolle Hospital, Tunisia

Diabetic nephropathy (DN) is the main cause of renal failure worldwide. DN is often associated with high blood pressure (BP), and these two pathologies seem to maintain each other. However, the impact of this nephropathy on the fluctuations of blood pressure is not well establish [....] » Read More

Faizah Albalawi, Speaker at Heart Conferences
Poster Presentation (In-Person)
Faizah Albalawi, Cardiff University, United Kingdom

Atherosclerotic cardiovascular disease (ACVD) is responsible for most global morbidity and mortality, contributing to a third of all deaths worldwide. ACVD is a low-grade chronic inflammatory disorder of the vasculature that is associated with build-up of lipids, cellular debris [....] » Read More

Naranjan S Dhalla, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Naranjan S Dhalla, St. Boniface Hospital Albrechtsen Research Centre, Canada

Although sudden cardiac death is considered to be a major mode of death in patients with heart failure, no satisfactory medical therapy is available for its prevention. Since over activation of sympathetic nervous system is invariably seen in subjects with high risk for sudden ca [....] » Read More

Thomas J Webster, Speaker at Heart Conferences
Keynote Presentation (In-Person)
Thomas J Webster, Hebei University of Technology, China

Nanomedicine has already provided dozens of FDA approved products improving the lives of billions. Most notably, nanomaterials have been used to develop vaccines for COVID, improved spinal implants, anti-infection materials without using antibiotics, and numerous drug delivery ve [....] » Read More

John R Doty, Speaker at Heart Conferences
Keynote Presentation (In-Person)
John R Doty, Intermountain Medical Center, United States

Aortic root replacement is an operation that requires resection of diseased aortic sinus tissue. Patients requiring aortic root replacement include those with combined aortic valve degeneration and aortic pathology, such as bicuspid aortic stenosis and root aneurysm. Other indica [....] » Read More

Miroslav Radenkovic, Speaker at Cardiology Conferences
Keynote Presentation (In-Person)
Miroslav Radenkovic, University of Belgrade, Serbia

Heart failure is a serious clinical syndrome with symptoms and signs provoked by a structural and functional cardiac abnormality, and coupled with elevated natriuretic peptide levels and evident pulmonary or systemic congestion. Regardless of outstanding improvements in the manag [....] » Read More

Nidhish Niranjan Nisty, Speaker at Cardiovascular Diseases Events
Oral Presentation (In-Person)
Nidhish Niranjan Nisty, Nisty Heart Centre, India

Introduction: Myocardial bridging is congenital coronary anomaly in which a segment of an epicardial coronary artery takes a tunnelled course under a bridge of the myocardium. This segment is compressed during systole, resulting in the so-called “milking effect” [....] » Read More

Asma Ayadi, Speaker at Cardiovascular Conference
Oral Presentation (In-Person)
Asma Ayadi, Tunisian Center for Nuclear Sciences and Technology, Tunisia

Arterial stiffness has emerged as a prominent marker of risk for cardiovascular disease. Few studies are interested in predicting symptomatic or asymptomatic arterial stiffness from hemodynamics and biomechanics parameters. Machine learning models can be used as an intelligent to [....] » Read More

Volodymyr Popov, Speaker at Heart Conferences
Oral Presentation (In-Person)
Volodymyr Popov, Amosov National Institute of Cardiovascular Surgery, Ukraine

Aim: To determine significance of patient-prosthesis mismatch (PPM) (indexed effective orifice area < 1,2 cm²/m²) after combined mitral-aortic valve replacement (MAVR) + TV`s plasty (TV) in pts with small cavity of left ventricle (SCLV) (end-diastolic volume (ED [....] » Read More

Olexandr Bolshak, Speaker at Heart Conferences
Oral Presentation (In-Person)
Olexandr Bolshak, Amosov National Institute of Cardiovascular Surgery, Ukraine

Aim:To research possibilities of surgical treatment of poststenotic aneurysms of ascending aorta (PAAA)  by different methods. Methods: During 2000-2023 yy 454 patients  (pts) with aortic stenoses (AS)   and PAAA  were consecutively operated in Inst [....] » Read More

Valery Boukarim, Speaker at Heart Conferences
Oral Presentation (In-Person)
Valery Boukarim, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective. To determined  possibillities of left atrium (LA)`s reduction by original method of arch plasty of LA (APLA) during mitral valve replacement (MVR) for isolated mitral valve disease (MVD). Methods. During 2005 – 2022 yy. 454  adult patients (pts) with [....] » Read More

Oleksii Gurtovenko, Speaker at Heart Conferences
Oral Presentation (In-Person)
Oleksii Gurtovenko, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To present analysis of retrograde crystalloid cardioplegia during combined valve pathology of mitral-aortic-tricuspid valve disease (matvd) . Materials and Methods: During 2009-2023 yy 529 patients (pts)  with (MATVD) were operated in Institute by CPB [....] » Read More

Volodymyr Popov, Speaker at Heart Conferences
Oral Presentation (In-Person)
Volodymyr Popov, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To determined  possibillities of correction of the left parts of the heart by preservation of MV`s apparatus and concomitant reduction of left atrium (LA) during correction of combined mitral-aortic-tricuspid valve diseases (CMATD). Methods: During 01.01.2006-0 [....] » Read More

Olexandr Bolshak, Speaker at Heart Conferences
Oral Presentation (In-Person)
Olexandr Bolshak, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To analyzed main problems  in surgery of  mitral valve diseases (MVD) complicated by left atrium`s massive thromboses (LAMT) (thromboses more than 1/3 of left atrium`s volume).  Materials And Methods 336 adult patients (pts) with MVD comp [....] » Read More

Valery Boukarim, Speaker at Heart Conferences
Oral Presentation (In-Person)
Valery Boukarim, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective. To determined  possibillities of left atrium (LA)`s reduction by original method of triangular plasty of LA (TPLA) during mitral valve replacement (MVR) for isolated mitral valve disease (MVD). Methods. During 2005 – 2022 yy. 725  adult patients (pts) [....] » Read More

Oleksii Gurtovenko, Speaker at Heart Conferences
Oral Presentation (In-Person)
Oleksii Gurtovenko, Amosov National Institute of Cardiovascular Surgery, Ukraine

Objective: To present analysis of pharmacological supporting of conditions of coronary artery and myocardium (pre and postcondition) during  combined mitral-aortic valve replacement (MVAR) + TV`s plasty . Materials and Methods: During 2015-2022 y 203 patients (p [....] » Read More

Syed Raza, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Syed Raza, Awali Hospital, Bahrain

Dyslipidaemia comprises  of abnormal lipid components  and  refers mainly to  increased levels of  LDL, non HDL particles and triglycerides while  decreased  levels of HDL Dyslipidaemia is a  common and independent  modifiable risk fac [....] » Read More

Mekhman N Mamedov, Speaker at Cardiovascular Conference
Keynote Presentation (Virtual)
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation

WHO considers diabetes mellitus (DM) to be a pandemic that has spread throughout the world. In some countries, this epidemic reaches >8% of the adult population, and in 20 years the frequency is expected to increase to 30-50%. Prospective studies have demonstrated that patient [....] » Read More

Roger H Coletti, Speaker at Cardiovascular Diseases Events
Keynote Presentation (Virtual)
Roger H Coletti, Interventional Health, United States

Throughout the body blood flow is regulated by vascular tone secondary to local or neurologic control. However, in the musculoskeletal system, the effects of muscular contraction can lead to augmentation of restriction of local blood flow. While repetitive muscle contraction incr [....] » Read More

 Ahdy W Helmy, Speaker at Heart Conferences
Keynote Presentation (Virtual)
Ahdy W Helmy, Indiana University School of Medicine, United States

Metabolic Dysfunction and Metabolic Syndrome birthed with visceral adiposity, and Insulin resistance has wide spread implications. From a bed of inflammation at the visceral adipose tissue core, RAAS activation and constricted vascular micro-perfusion. To hyperinsulinemia and vol [....] » Read More

Zuowei Pei, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Zuowei Pei, Central Hospital Of Dalian University Of Technology, China

Hypertensive?HTN? is one of the risk factors for cardiovascular disease, and exercise has a protective effect on the heart. However, the mechanism by which exercise affects HTN-induced myocardial damage is unclear. In this study, the exercise response model of HTN myocardial inju [....] » Read More

 Zhongchen Li, Speaker at Heart Conferences
Oral Presentation (Virtual)
Zhongchen Li, Fuwai Hospital, China

Background: The triglyceride-glucose (TyG) index, which is a reliable substitute indicator for insulin resistance, has been considered an independent risk factor for long-term outcomes in patients with cardiovascular disease. However, at present, only a limited number of stu [....] » Read More

Mengyi Liu, Speaker at Heart Conferences
Oral Presentation (Virtual)
Mengyi Liu, Chinese Academy of Medical Sciences, China

Background: Acute kidney injury (AKI) is a common complication following coronary artery bypass grafting (CABG) surgery, with an incidence of 30-60%, significantly impacting both short-term and long-term mortality. In patients undergoing CABG, severe multivessel coronary art [....] » Read More

Yin Xiaoyang, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yin Xiaoyang, Beijing University of Chinese Medicine, China

Objective: Currently, atherosclerosis and hyperuricemia remain among the most challenging metabolic disorders globally. Extensive epidemiological surveys and clinical studies have indicated a potential pathological link between hyperuricemia and atherosclerosis, even suggesting a [....] » Read More

Yadi Liu, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Yadi Liu, Beijing University of Chinese Medicine, China

Objective: Based on the phenomenon of elevated blood uric acid in patients with clinical adriamycin cardiac injury, to explore the effect of high uric acid on the progression of adriamycin cardiotoxicity. Methods: Adriamycin cardiotoxicity mouse model was established by intraper [....] » Read More

 Zhongchen Li, Speaker at Heart Conferences
Oral Presentation (Virtual)
Zhongchen Li, Fuwai Hospital, China

Background: Lipoprotein(a) has been implicated as a pathogenic risk factor for atherosclerosis and its complications. The triglyceride-glucose (TyG) index, a novel surrogate marker for insulin resistance (IR), has been identified as an independent predictor of adverse cardia [....] » Read More

Mengyi Liu, Speaker at Heart Conferences
Oral Presentation (Virtual)
Mengyi Liu, Chinese Academy of Medical Sciences, China

Background: Postoperative atrial fibrillation (POAF) is the most common complication following coronary artery bypass grafting (CABG), which increases the risk of stroke and mortality, prolongs the length of hospital stays, and leads to higher healthcare costs. Structural ch [....] » Read More

Jamuna Rani Ayyalu, Speaker at Heart Conferences
Oral Presentation (Virtual)
Jamuna Rani Ayyalu, Sree Balaji Medical College And Hospital, India

Management of stress by yogic practices like Surya Namaskar, Pranayama and Meditation. Medical education includes the strenuous course load and hectic schedule, most students have a lack of time to take care of health and relaxation techniques. Yoga is gaining prominence in impro [....] » Read More

Prima Abdillah Akbar, Speaker at Heart Conferences
Oral Presentation (Virtual)
Prima Abdillah Akbar, Airlangga University, Indonesia

Introduction: Numerous investigations examining fenestration in the Fontan procedure have presented inconsistent findings regarding its effectiveness in improving surgical outcomes. The objective of this meta -analysis is to contrast the early results of fenestrated versus non-fe [....] » Read More

Marina A Chichkova, Speaker at Heart Conferences
Oral Presentation (Virtual)
Marina A Chichkova, Federal State Budgetary Institution, Russian Federation

A new coronavirus infection identified by the World Health Organization Committee as COVID-19 ("Coronavirus disease 2019") with the official name of the causative agent of infection – SARS-CoV-2. Some patients develop hypercoagulation syndrome with thrombosis [....] » Read More

Vikram Jitendra, Speaker at Heart Conferences
Oral Presentation (Virtual)
Vikram Jitendra, Aberdeen Royal Infirmary, United Kingdom

Aortic stenosis is the most common valvular disease and has a poor prognosis without surgical treatment. The use of sutureless valves (SV) has been emerging as a promising surgical option in certain patient populations especially in the elderly, frail and in redo cardiac procedur [....] » Read More

Yasser Mohammed Hassanain Elsayed, Speaker at Heart Conferences
Oral Presentation (Virtual)
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt

Background: Arrhythmias are one of the most serious disorders in cardiovascular and clinical medicine. Understanding the pathogenesis and mechanisms of arrhythmias is very advantageous to the appropriate management and treatment of all arrhythmia types. The “Graded phenomen [....] » Read More

Joao Rafael Rocha Da Silva, Speaker at Heart Conferences
Oral Presentation (Virtual)
Joao Rafael Rocha Da Silva, Connect Life Rehabilitation And Performance, Brazil

Chronic pain is defined as persistent pain for more than three months and can be classified as primary with no known etiology, or secondary pertinent to a pathological process and specific clinical diagnosis.In previous studies, we observed that it directly impacts cardiac rehabi [....] » Read More

Iris Panagiota Efthymiou, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Iris Panagiota Efthymiou, University of East London, United Kingdom

The pursuit of cardiovascular wellness is of paramount global concern, touching the lives of many individuals and societies. Understanding the intricate interplay between economics and behavior in the context of heart health is pivotal for crafting effective strategies to mitigat [....] » Read More

Paraskevi Theofilou, Speaker at Heart Conferences
Oral Presentation (Virtual)
Paraskevi Theofilou, General Hospital of Thoracic Diseases Sotiria, Greece

Exercise is an important factor of rehabilitation in heart failure patients, improving several indicators of disease prognosis and functional capacity. The aim of the present study was to examine the effect of a cardiorespiratory rehabilitation program on the physical and mental [....] » Read More

Eesha Wahid, Speaker at Heart Conferences
Oral Presentation (Virtual)
Eesha Wahid, Trinity College Dublin, Ireland

Increased physiological demands coupled with haemodynamic changes occurring during pregnancy pose a unique and significant challenge to the cardiovascular system.  Pregnant women are at risk of suffering from the exacerbation of pre-existing cardiovascular disease (CVD) as w [....] » Read More

 Maria Borrell, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Maria Borrell, Sant Pau Institute for Biomedical Research, Spain

Atherosclerosis, the leading cause of cardiovascular diseases, is driven by high blood cholesterol levels and chronic inflammation. The disruption of the hepatic interaction between Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) and Low-Density Lipoprotein Receptor (LDLR) downr [....] » Read More

James V Cireddu , Speaker at Heart Conferences
Oral Presentation (Virtual)
James V Cireddu , Case Western University, United States

Telehealth is a growing field of importance, but the loss of comprehensive physical exam data creates barriers to managing complex heart failure patients.  Innovative digital tools such as VPExam Virtual Care combine augmented reality guidance of video acquisitions with Blue [....] » Read More

Elizabeth C Ghandakly, Speaker at Heart Conferences
Oral Presentation (Virtual)
Elizabeth C Ghandakly, Cleveland Clinic Foundation, United States

Recommendations for the primary prevention of cardiovascular disease (CVD) vary by global region. This variability occurs by nature of different practice guidelines being put forth by separate regional cardiology societies, such as The American College of Cardiology/American Hear [....] » Read More

Catherine Le, Speaker at Heart Conferences
Oral Presentation (Virtual)
Catherine Le, University of Montreal, Canada

It is known that oxidized low density lipoproteins (oxLDL) interaction with the cluster of differentiation 36 (CD36)/SR-B2, a scavenger membrane protein, at the surface of macrophages, leads to an internalization of oxLDL in the cells. During atherosclerosis development, an exces [....] » Read More

Helen Senderovich, Speaker at Cardiovascular Conference
Oral Presentation (Virtual)
Helen Senderovich, Baycrest Health Sciences, Canada

Introduction: Congestive heart failure (CHF) is an increasingly prevalent terminal illness in a globally aging population. Despite optimal medical management, prognosis remains poor – a fact seldom communicated to patients and/or their families.  Evidence suggests [....] » Read More

Ayisha Zaka Bashir, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Ayisha Zaka Bashir, University of Nebraska Medical Center, United States

Peripheral artery disease (PAD) is a cardiovascular disease affecting more than 8.5 million Americans over the age of 40 years and is prevalent in the geriatric cardiology population. PAD is a manifestation of systemic atherosclerosis, characterized by atherosclerotic blockages o [....] » Read More

Corey Tabit , Speaker at Heart Conferences
Oral Presentation (Virtual)
Corey Tabit , University of Chicago, United States

Cardiovascular disease is the #1 killer of adults worldwide, with low-socioeconomic urban patients more severely affected.  Social Determinants of Health (SDOH) such as community violence, elements of the built environment, income, literacy, and access to food and pharmacy a [....] » Read More

Tahmineh Azizi, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Tahmineh Azizi, University of Wisconsin-Madison, United States

In this study, we explore the possibility that ECG recordings belong to class of multifractal process for which a large number of scaling exponents are required to characterize their scaling structures. We use the BIDMC Congestive Heart Failure database including long term ECG re [....] » Read More

Asma Syed, Speaker at Cardiology Conferences
Oral Presentation (Virtual)
Asma Syed, Brookdale Hospital Medical Center -OBH, United States

Will be Updated Soon...

Corey Tabit , Speaker at Heart Conferences
Oral Presentation (Virtual)
Corey Tabit , University of Chicago, United States

While cardiovascular disease remains the most common cause of death worldwide, clinical approaches to the management of common cardiovascular conditions such as heart failure, coronary artery disease, and atrial fibrillation vary widely from institution to institution and from pr [....] » Read More

Samir Morcos Rafla, Speaker at Cardiovascular Diseases Events
Oral Presentation (Virtual)
Samir Morcos Rafla, Alexandria University, Egypt

Most palpitations in pregnancy are benign and usually occur due to atrial or ventricular premature complexes. Careful consideration should be given to the gestation stage and the patient's hemodynamic state. In hemodynamically stable pregnant patients with acute onset of [....] » Read More

Robert Guidon, Speaker at Heart Conferences
Oral Presentation (Virtual)
Robert Guidon, Laval University, Canada

Background: The donkey pericardium is considered to be a good candidate material for use in the manufacture of percutaneous heart valves based upon its thinness, its low cellularity and its undulating collagen bundles and laminates. Decellularization represents an avenue worth ex [....] » Read More

Robert Guidon, Speaker at Heart Conferences
Oral Presentation (Virtual)
Robert Guidon, Laval University, Canada

Background: The donkey pericardium is considered to be a good candidate material for use in the manufacture of percutaneous heart valves based upon its thinness, its low cellularity and its undulating collagen bundles and laminates. Decellularization represents an avenue worth ex [....] » Read More

Dae Wook Lee, Speaker at Cardiovascular Conference
Poster Presentation (Virtual)
Dae Wook Lee, Novartis Pharmaceuticals, Korea, Republic of

In the rapidly evolving landscape of healthcare, the role of Medical Affairs (MA) is increasingly pivotal in the successful launch of new molecular entities (NMEs). This abstract delves into the innovative approaches that are revolutionizing MA, specifically focusing on how these [....] » Read More

Shenghan Zhong, Speaker at Heart Conferences
Poster Presentation (Virtual)
Shenghan Zhong, Chongqing Kanghua Zhonglian Cardiovascular Hospital, China

Background: This study aims to evaluate the efficacy, safety, and long-term effects of sacubitril/valsartan in treating hypertrophic cardiomyopathy using a hypertrophic cardiomyopathy rat model and in vitro cardiomyocytes. Hypertrophic cardiomyopathy presents a challenge in cardi [....] » Read More

Grace Qiu, Speaker at Heart Conferences
Poster Presentation (Virtual)
Grace Qiu, Thomas Jefferson University, United States

Background: It is well known that conventional right ventricular (RV) pacing results in left ventricular dyssynchrony. Approximately 30% of patients with normal baseline ejection fraction (EF) and >40% of RV pacing will go on to develop cardiomyopathy and heart failure. Conduc [....] » Read More

Watsapp